Fine-Needle Aspiration

Fine-needle aspiration is a biopsy that uses a very thin needle to draw out cells from a lump, lymph node or fluid collection. It is quick and low-risk, but it collects loose cells rather than a piece of tissue, so it often cannot confirm mesothelioma on its own.

Origin

Doctors at Memorial Hospital in New York reported needle aspiration of tumors in the 1930s, and the technique was developed widely in Sweden in the decades that followed. It is now routine, often guided by ultrasound, CT or an endoscope.

Significance in Asbestos Context

For mesothelioma, the main problem is that the defining feature, invasion of tumor cells into the tissue beneath the lining, cannot be seen in a smear of loose cells. Reactive mesothelial cells can also look abnormal, so cytology alone risks both false positives and false negatives. Fine-needle aspiration is still useful: it can sample lymph nodes during staging, confirm lung cancer, and provide cells for a cell block, where immunostains and tests such as BAP1 and MTAP may support a diagnosis. Most mesothelioma specialists prefer a core needle biopsy or a thoracoscopic biopsy for the first diagnosis. For a claim, a diagnosis based only on fine-needle aspiration may be challenged, so later tissue confirmation, or strong supporting tests on the aspirate, makes the record more secure.

Example Sentence

The fine-needle aspiration of the lymph node showed malignant cells, but the team took a core biopsy of the pleura to confirm mesothelioma and its subtype.

Related Terms

Needle Biopsy, Aspirate, Cytology, Cell Block, Thoracoscopic Biopsy, Biopsy, Reactive Mesothelial Cells, Immunohistochemistry

Notes

• Ask whether your diagnosis came from cells (cytology) or from a tissue biopsy.
• If only cells were sampled, ask whether a tissue biopsy is needed to confirm the diagnosis and subtype.
• Ask the lab to keep the slides and any cell block.